COMPASS Pathways plc - Ordinary Shares, par value GBP 0.008 per share (CMPS)
CUSIP: 20451W101
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Ordinary Shares, par value GBP 0.008 per share
- Shares outstanding
- 131,025,970
- Total 13F shares
- 92,460,732
- Share change
- +37,782,949
- Total reported value
- $511,172,811
- Put/Call ratio
- 312%
- Price per share
- $5.53
- Number of holders
- 189
- Value change
- +$202,737,387
- Number of buys
- 122
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP 20451W101?
CUSIP 20451W101 identifies CMPS - COMPASS Pathways plc - Ordinary Shares, par value GBP 0.008 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 20451W101:
Top shareholders of CMPS - COMPASS Pathways plc - Ordinary Shares, par value GBP 0.008 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13D/G
13F
|
Company |
9.9%
|
12,971,571
|
$71,732,788 | +$19,339,372 | 31 Mar 2026 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
10%
from 13D/G
|
7,334,323
|
$50,606,829 | — | 31 Dec 2025 | |
| Atai Beckley N.V. |
3/4/5
13D/G
|
10%+ Owner · ATAI Life Sciences N.V. |
6%
from 13D/G
|
6,905,774
|
$41,779,933 | — | 26 Sep 2024 | |
| Ekaterina Malievskaia |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,307,970
|
$38,163,218 | — | 24 Oct 2024 | |
| George Jay Goldsmith |
3/4/5
13D/G
|
10%+ Owner |
2.4%
from 13D/G
|
6,307,970
|
$38,163,218 | — | 24 Oct 2024 | |
| AtaiBeckley Inc. |
13D/G
|
— |
5%
|
4,764,710
|
$37,260,032 | $0 | 21 Jan 2026 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
3.6%
|
3,484,315
|
$19,965,125 | -$14,038,500 | 30 Sep 2025 | |
| GMT CAPITAL CORP |
13F
|
Company |
2.2%
|
2,844,618
|
$19,627,864 | — | 31 Dec 2025 | |
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
3.2%
|
3,174,494
|
$18,189,851 | -$18,189,851 | 30 Sep 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
1.9%
|
2,529,013
|
$17,446,594 | — | 31 Dec 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
1.6%
|
2,156,012
|
$14,876,481 | — | 31 Dec 2025 | |
| TCG Crossover GP I, LLC |
13D/G
|
Chen Yu |
3.9%
|
3,858,000
|
$14,197,440 | $0 | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
1.6%
|
2,038,444
|
$14,065,263 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.3%
|
1,644,242
|
$11,345,270 | — | 31 Dec 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
1.2%
|
1,576,905
|
$10,880,645 | — | 31 Dec 2025 | |
| Eagle Health Investments LP |
13F
|
Company |
1.2%
|
1,519,388
|
$10,483,777 | — | 31 Dec 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
3%
|
2,773,521
|
$10,456,174 | -$2,412,525 | 31 Mar 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
1,453,876
|
$10,031,744 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,387,658
|
$9,574,840 | — | 31 Dec 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
0.91%
|
1,198,418
|
$8,269,084 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.87%
|
1,137,520
|
$7,848,890 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.76%
|
1,000,000
|
$6,900,000 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.74%
|
967,846
|
$6,678,137 | — | 31 Dec 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.66%
|
861,778
|
$5,946,268 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.65%
|
856,500
|
$5,909,850 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.64%
|
844,816
|
$5,829,230 | — | 31 Dec 2025 | |
| Kalehua Capital Management LLC |
13F
|
Company |
0.63%
|
819,692
|
$5,655,875 | — | 31 Dec 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.62%
|
811,046
|
$5,596,217 | — | 31 Dec 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.6%
|
779,618
|
$5,379,364 | — | 31 Dec 2025 | |
| NEXTBio Capital Management LP |
13F
|
Company |
0.57%
|
752,631
|
$5,193,154 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.49%
|
645,065
|
$4,450,948 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13D/G
13F
|
Kenneth Griffin · Company |
1.7%
|
1,166,576
|
$4,397,992 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.45%
|
594,269
|
$4,100,456 | — | 31 Dec 2025 | |
| CenterBook Partners LP |
13F
|
Company |
0.44%
|
578,828
|
$3,993,913 | — | 31 Dec 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.44%
|
570,462
|
$3,833,505 | — | 31 Dec 2025 | |
| HighVista Strategies LLC |
13F
|
Company |
0.38%
|
498,933
|
$3,442,637 | — | 31 Dec 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.36%
|
469,914
|
$3,242,407 | — | 31 Dec 2025 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.32%
|
424,800
|
$2,931,120 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.31%
|
400,000
|
$2,760,000 | — | 31 Dec 2025 | |
| Squadron Capital Management LLC |
13F
|
Company |
0.3%
|
388,287
|
$2,679,180 | — | 31 Dec 2025 | |
| Kabir Nath |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
734,805
mixed-class rows
|
$2,532,231 | — | 26 Mar 2026 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.26%
|
336,728
|
$2,323,423 | — | 31 Dec 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.22%
|
290,000
|
$2,001,000 | — | 31 Dec 2025 | |
| BIT Capital GmbH |
13F
|
Company |
0.22%
|
288,814
|
$1,992,817 | — | 31 Dec 2025 | |
| Founders Fund VII Management, LLC |
13F
|
Company |
0.21%
|
278,880
|
$1,924,272 | — | 31 Dec 2025 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.21%
|
275,773
|
$1,902,834 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
0.19%
|
247,337
|
$1,706,625 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.19%
|
247,337
|
$1,706,625 | — | 31 Dec 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.18%
|
230,910
|
$1,593,279 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.17%
|
218,406
|
$1,507,001 | — | 31 Dec 2025 |
Institutional Holders of COMPASS Pathways plc - Ordinary Shares, par value GBP 0.008 per share (CMPS) as of Q1 2026
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.